Arkema to Start Singapore PA 11 Plant in 2022
The French company’s total investment in the region, which also includes downstream polymer capacities in China, is budgeted at €450 million. To finance the new Singapore facility for its Rilsan-branded PA specialty, Arkema placed its first-ever “green bond” in October 2020, with a value of €300 million.
With the project, which reportedly was held up by the Covid-19 pandemic, Arkema said it is delivering on its “strong commitment” to specialty materials and the bio-based polyamide 11 chain. When complete, the company said this will be “the biggest integrated bio-factory in the world dedicated to high performance polymers.”
The chemicals and high-end plastics producer said the project supports strong growth in demand for its advanced bio-circular materials. The polyamide, which it said is recognized for its superior properties and performance in demanding applications, “significantly contributes to the development of sustainable solutions in fast-growing sectors, such as new energy vehicles and 3D printing, as well as consumer goods, electronics, sports and lifestyle markets.”
Author: Dede Williams, Freelance Journalist
-
Arkema said it is on track to produce its high performance PA 11 and feedstock aminoundecanoic acid at a new plant on Singapore’s Jurong Island in the first half of 2022. The project announced in 2017 calls for a 50% increase in the company’s global PA 11 capacity. (c) Arkema
